-
Post date
July 22, 2021
-
Posted by
Piers Eaton
-
Posted in
American Exchanges, Biotech, cybin, CYBN, CYBN.NE, Eaton, Health Science, Mushrooms, Nasdaq, NYSE, NYSE American, OTCQB, Psychedelics, Scribes, Uplisting
-
Post date
July 13, 2021
-
Posted by
Piers Eaton
-
Posted in
13th Provisional Patent, Biotech, cybin, CYBN.NE, Eaton, Health Science, Mushrooms, Patent Application, psilocybin, Psychedelics, Scribes, Telemedicine
-
Post date
July 6, 2021
-
Posted by
Piers Eaton
-
Posted in
Biotech, Centers of Excellence, CYB001, cybin, CYBN.NE, Eaton, Greenbrook TMS, Health Science, mental health, Mushrooms, psilocybin, Psychedelics, R&D, Scribes, TMS NeuroHealth Centers, Wellness
-
Post date
June 28, 2021
-
Posted by
Piers Eaton
-
Posted in
Adelia Therapeutics, Biotech, Cash on had, Cash on hand, cybin, CYBN.NE, Eaton, financial results, Health Science, Milestones, mushroom, Mushrooms, psilocybin, Psychedelics, research, Science, Scribes, shrooms
-
Post date
June 16, 2021
-
Posted by
Piers Eaton
-
Posted in
CYB004, cybin, CYBN.NE, GAD, Generalized Anxiety Disorder, Health Science, mental health, Mushroom Moves, Mushrooms, psilocybin, Psychedelics, SAD, Series, shrooms, Social Anxiety Disorder